Abstract
Background
The disproportionate increase in the super obese (SO) is a hidden component of the current obesity pandemic. Data on the safety and efficacy of bariatric procedures in this specific patient population are limited. Our aim is to assess the comparative effectiveness of the two most common bariatric procedures in the SO.
Methods
Using the Bariatric Outcomes Longitudinal Database from 2007 to 2012, we compared SO patients (BMI ≥ 50) undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). Stepwise logistic regression modeling was used to calculate a propensity score to adjust for patient demographics and comorbidities.
Results
We identified 50,987 SO patients who underwent RYGB (N = 42,119) or SG (N = 8868). There was no difference in adjusted overall 30-day complication rate comparing RYGB and SG patients (11.5 vs. 11.1 %, p = 0.250). RYGB patients had higher adjusted rates of 30-day mortality (0.3 vs. 0.2 %, p = 0.042), reoperation (4.0 vs. 2.4 %, p < 0.001), and readmission (6.9 vs. 5.5 %, p < 0.001) compared to SG patients. The percent of total weight loss (%TWL) was significantly higher for RYGB patients compared to SG at 3 months (14.1 vs. 13.1 %, p < 0.001), 6 months (25.2 vs. 22.4 %, p < 0.001), and 12 months (34.5 vs. 29.7 %, p < 0.001). RYGB patients had increased resolution of all measured comorbidities: diabetes mellitus (61.6 vs. 50.8 %, p < 0.001), hypertension (43.1 vs. 34.5 %, p < 0.001), gastroesophageal reflux disease (53.9 vs. 32.5 %, p < 0.001), hyperlipidemia (39.7 vs. 32.5 %, p < 0.001), and obstructive sleep apnea (42.8 vs. 40.6 %, p = 0.058) at 12 months compared to SG patients.
Conclusions
There are significant differences in comorbidity improvement and resolution as well as weight loss between RYGB and SG in the SO population. There was no difference in overall 30-day complications, but more RYGB patients required readmission and reoperation. However, RYGB was considerably more effective in controlling obesity-related comorbidities. Our results favor performance of RYGB in SO patients of appropriate risk.
Similar content being viewed by others
References
Sturm R (2003) Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med 163:2146
Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491
Prachand VN, Ward M, Alverdy JC (2009) Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 14:211–220
Colquitt JL, Pickett K, Loveman E, Frampton GK (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev. doi:10.1002/14651858.CD003641.pub4
Ikramuddin S, Korner J, Lee W-J, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang L-M, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. JAMA 309:2240
Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, Pothier CE, Brethauer S, Nissen S, Gupta M, Kirwan JP, Schauer PR (2013) Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 36:2175–2182
Oʼbrien PE, Macdonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery. Ann Surg 257:87–94
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:246–256
Pories WJ, Swanson MS, Macdonald KG, Long SB, Morris PG, Brown BM, Barakat HA, Deramon RA, Israel G, Dolezal JM, Dohm L (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–352
Telem DA, Talamini M, Shroyer AL, Yang J, Altieri M, Zhang Q, Gracia G, Pryor AD (2014) Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery. Surg Endosc 29:529–536
Andreyeva T, Sturm R, Ringel JS (2004) Moderate and severe obesity have large differences in health care costs. Obes Res 12:1936–1943
Zerrweck C, Sepúlveda EM, Maydón HG, Campos F, Spaventa AG, Pratti V, Fernández I (2013) Laparoscopic gastric bypass vs. sleeve gastrectomy in the super obese patient: early outcomes of an observational study. Obes Surg 24:712–717
Joshi GP, Ahmad S, Riad W, Eckert S, Chung F (2014) Selection of obese patients undergoing ambulatory surgery. Surv Anesthesiol 58:57
Serrano OK, Tannebaum JE, Cumella L, Choi J, Vemulapalli P, Melvin WS, Camacho DR (2015) Weight loss outcomes and complications from bariatric surgery in the super super obese. Surg Endosc. doi:10.1007/s00464-015-4509-y
Abeles D, Kim JJ, Tarnoff ME, Shah S, Shikora SA (2009) Primary laparoscopic gastric bypass can be performed safely in patients with BMI ≥ 60. J Am Coll Surg 208:236–240
Gould JC, Garren MJ, Boll V, Starling JR (2006) Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients. Surgery 140:524–531
Zak Y, Petrusa E, Gee DW (2015) Laparoscopic Roux-en-Y gastric bypass patients have an increased lifetime risk of repeat operations when compared to laparoscopic sleeve gastrectomy patients. Surg Endosc 30:1833–1838
Young MT, Gebhart A, Phelan MJ, Nguyen NT (2015) Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg 220(5):880–885
Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m2). Surg Today 38:399–403
Alexandrou A, Felekouras E, Giannopoulos A, Tsigris C, Diamantis T (2012) What is the actual fate of super-morbid-obese patients who undergo laparoscopic sleeve gastrectomy as the first step of a two-stage weight-reduction operative strategy? Obes Surg 22:1623–1628
Spaniolas K, Kasten KR, Brinkley J, Sippey ME, Mozer A, Chapman WH, Pories WJ (2015) The changing bariatric surgery landscape in the USA. Obes Surg 25:1544–1546
Reames BN, Finks JF, Bacal D, Carlin AM, Dimick JB (2014) Changes in bariatric surgery procedure use in Michigan, 2006–2013. JAMA 312:959
Demaria EJ, Pate V, Warthen M, Winegar DA (2010) Baseline data from American society for metabolic and bariatric surgery-designated bariatric surgery centers of excellence using the bariatric outcomes longitudinal database. Surg Obes Relat Dis 6:347–355
Sczepaniak JP, Owens ML, Shukla H, Perlegos J, Garner W (2014) Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008–2011. Obes Surg 25:788–795
Thereaux J, Corigliano N, Poitou C, Oppert JM, Czernichow S, Bouillot JL (2015) Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI > 50 kg/m2. Surg Obes Relat Dis 11(4):785–790
Khan S, Rock K, Baskara A, Qu W, Nazzal M, Ortiz J (2015) Trends in bariatric surgery from 2008 to 2012. Am J Surg 211:1041–1046
Li J, Lai D, Wu D (2015) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26:429–442
Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M, Schultles B, Laederach K, Bueter M, Schiesser M (2013) Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258(5):690–694
Bays HE, Chapman RH, Grandy S (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 61:737–747
Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH (2007) Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12:250–255
Suter M, Calmes JM, Paroz A, Romy S, Giusti V (2009) Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life. Arch Surg 144(4):312–318
Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ (2005) Laparoscopic bariatric surgery in super-obese patients (BMI > 50) is safe and effective: a review of 332 patients. Obes Surg 15:858–863
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Drs. Celio, Wu, Kasten, Manwaring, Pories, and Spaniolas have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Celio, A.C., Wu, Q., Kasten, K.R. et al. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients. Surg Endosc 31, 317–323 (2017). https://doi.org/10.1007/s00464-016-4974-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-016-4974-y